[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 1956

Explosion-Proof Apparatus for the Treatment of Ventricular Fibrillation

Author Affiliations

Boston; Indianapolis; Baltimore; Los Angeles
Research Associate in Surgery, Harvard Medical School (Mr. Claff); Department of Surgery, Indiana University School of Medicine (Dr. Kaiser); Department of Surgery, Johns Hopkins University and Hospital (Dr. Gaertner), and Department of Surgery, University of Southern California School of Medicine (Dr. Kay).

AMA Arch Surg. 1956;73(6):943-946. doi:10.1001/archsurg.1956.01280060043009

The incidence of ventricular fibrillation is increasing because of the large number of thoracic and cardiac procedures being performed. Many cases of ventricular fibrillation occur in one year in a large hospital and several times in one week in cardiac centers. Although the incidence of ventricular fibrillation is greater during operations on the chest, it may occur during any operative procedure and with any anesthetic agent. Consequently, it is important that the members of every operating team be able to treat ventricular fibrillation and standstill and that every suite of operating rooms have an electrical defibrillator.

The defibrillator should be simple in design and easy to operate and should deliver what appears at this time to be the optimal voltages at the optimal durations. The apparatus should be so constructed as to safeguard both the patient and the operating room personnel; of necessity, therefore, it must be explosion-proof. Because none